Aha23

These aha23 studies were featured during AHA What will happen in ?

The health and safety of our members, attendees, exhibitors, hotel staff, and the people of Philadelphia are our primary concerns. We are paying close attention to the situation in the city and state, as well as regional and national transportation issues, and will adjust our plans and policies as necessary as the situation evolves. Attendees should comply with any mask and social distancing rules and guidelines established by the AHA, which will follow the guidance of the CDC as well as any additional requirements set by the conference hotels and the local government. We will regularly update members on health and safety guidelines via our website. The city of Philadelphia is well vaccinated and we have been impressed by the stringent policies, benchmarks, and data analytics established by Philadelphia public health officials. We will follow whatever masking protocols are necessary for health and safety, including adhering to the strictest standards set by the Centers for Disease Control, city and state public health officials, and the meeting hotels.

Aha23

Dr Honigberg provides commentary on the new SELECT trial outcomes and emphasises the incretin mimetic, semaglutide's role in cardiovascular medicine. He delves into lipid management with a focus on the CLEAR trial data and the incorporation of bempedoic acid into existing treatment paradigms. The CANTOS trial's exploration of colchicine in coronary artery disease patients is another focal point, with Dr Honigberg sharing his experiences integrating it into his therapeutic arsenal. Furthermore, Dr Honigberg underscores the growing recognition of cardiometabolic health that encourages more holistic approaches to cardiac health. Notably, Dr Honigberg addresses the importance of recognising social determinants of health and advocates for their integration into treatment strategies. ICR 3. USC is the official journal of the CardioNerds. About USC. Editorial Board. For Authors. Special Collections.

If you are not registered, you can register here.

.

Group Registration Discount pricing is available for groups of 40 or more. Information on refunds, deadlines, policies, badge information and more for Scientific Sessions. During the registration process, attendees will be asked to confirm their agreement with this information. To sign up, please complete an application before November 3, Learn more about Professional Membership. Contact: [email protected] Phone: Monday through Friday, 9 a. Conference Contact: [email protected] Phone: or For membership status questions or Professional Heart Daily account questions contact: American Heart Association [email protected].

Aha23

These practice-changing studies were featured during AHA What will happen in ? Be a part of the premier global event for advancements in cardiovascular science and medicine. Experience the highest tier of scientific discovery and practice-changing educational content. Focus on your specialty and engage with experts, or expand your knowledge through discussions, resources and interaction with notable peers. This conference is focused on the latest innovations for scientists, clinicians, researchers and other healthcare professionals interested in any and all aspects of cardiovascular disease. Discover the robust scientific and clinical learning portfolio of programming across an array of specialties. Network with a multitude of colleagues at the conference known for playing a pivotal role in training young and diverse researchers.

Gw2 map

Nancy M. Marraro Prize George L. Special Collections. And it takes some learning and there is a bit of a learning curve with that. Experience the highest tier of scientific discovery and practice-changing educational content. For Authors. AHA Policies and Guiding Values The American Heart Association policies on conflict of interest, ethics and inclusiveness and our guiding values reflect the high standard of business conduct that has always been, and remains, a hallmark of our organization. The health and safety of our members, attendees, exhibitors, hotel staff, and the people of Philadelphia are our primary concerns. Also noting relatedly the recent FDA approval of tirzepatide for weight management, the dual GLP receptor agonist GIP analogue, the Cardiovascular Outcomes Trial of tirzepatide is ongoing and slated to report out in several years. We will accommodate presenters who are not comfortable meeting in person. We will work with our exhibitor services company, the hotels, and local public health officials to comply with all social distancing guidelines in the Exhibit Hall and registration area. The third, I think notable development this year is the FDA approval of colchicine for cardiovascular risk reduction. Attendees should comply with any mask and social distancing rules and guidelines established by the AHA, which will follow the guidance of the CDC as well as any additional requirements set by the conference hotels and the local government. The meeting hotels assure us that their air filtration and air mass refresh levels are at the highest quality, consistent with Marriott International and Loews Hotels best practices.

There are numerous ways to catch up with old friends or meet new people at the annual meeting. Newcomers are encouraged to join us at Getting the Most Out of the Annual Meeting , an orientation for first-time attendees.

Notably, Dr Honigberg addresses the importance of recognising social determinants of health and advocates for their integration into treatment strategies. Furthermore, Dr Honigberg underscores the growing recognition of cardiometabolic health that encourages more holistic approaches to cardiac health. And it takes some learning and there is a bit of a learning curve with that. December 15 Last day for preregistration pricing. Corey Prize Recipients Raymond J. The city of Philadelphia is well vaccinated and we have been impressed by the stringent policies, benchmarks, and data analytics established by Philadelphia public health officials. ICR 3. Conference Contact: [email protected] Phone: or If you are not registered, you can register here. And I think related to all of these previous four points is just the fifth point that I wanted to highlight briefly, which is a growing recognition of the social determinants of health and health inequities as being such strong background structural drivers of cardiovascular outcomes.